Olympus has commercially made HANAROSTENT Esophagus TTS Stent available in the market.
FREMONT, CA: Olympus, one of the leading global medical and surgical technology solution providers, has launched HANAROSTENT Esophagus Through-the-Scope (TTS) Stent. Delivering innovative solutions to empower medical and surgical procedures, the company has been making its move towards the idealization of the medical industry with the new HANAROSTENT® Esophagus TTS self-expanding metal stents. This product is developed by M.I. Tech and distributed exclusively by Olympus in the U.S. this Esophagus stent is a new addition to the suite of self-expanding stents of Olympus.
The new 10.5F HANAROSTENT Esophagus TTS stent offering focuses on delivering highly accurate and increasingly simple esophageal stenting assistance by using the concept of direct endoscopic visualization. The product features reduced use of fluoroscopy as the stent follows the approach f directly visualizing the lumen. HANAROSTENT also supports a unique wire structure that provides optimized radial and axial force that minimizes the impact of painful retrosternal pressure. Other features include Increased Procedural Efficiency that further increases the outcomes and the rate of success.
Olympus is a leader in the realm of medical and surgical technology. The company holds the mission to empower medical and surgery practitioners by providing them with innovative and futuristic solutions that cater to the medical, life sciences, and industrial equipment industries. Olympus has a team of highly brilliant and smart developers and professionals who come up with innovations in medical devices that take the industry forward into success. The company also expends its expertise into other verticals such as therapeutic intervention and precision manufacturing. With this, Olympus helps medical experts access diagnostic, therapeutic, and minimally invasive procedures to improve treatment outcomes and enhance patient experiences.